Nasal spray flu vaccines are an alternative to traditional injectable flu shots.
As of October 21, 2025, they are approved for use in healthy, non-pregnant individuals aged 2 through 49 years by the CDC.
How They Work: The nasal spray contains a live, weakened form of the flu virus. When administered into the nostrils, it stimulates an immune response in the mucosal lining of the respiratory tract, mimicking natural infection without causing illness in healthy people.
Studies show LAIV can be as effective as the injectable vaccine in healthy individuals, though efficacy varies year to year depending on how well it matches circulating strains. Recent updates in 2025 have improved strain selection based on global surveillance data.
It's needle-free, making it a popular choice for those who dislike shots. It's also convenient, often available at pharmacies or clinics, and can be a good option for kids or adults who tolerate it well.
The spray is not suitable for everyone'people with weakened immune systems, certain chronic conditions (such as asthma), or those in close contact with immunocompromised individuals should stick to the shot.
Nasal spray vaccines are widely accessible in the U.S., often stocked alongside injectable options. Check with your healthcare provider or local pharmacy for the latest supply.
